Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Lower Risk of Mortality for Shock Patients Transferred to Expert Centers

Caitlin E. Cox

March 17, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Features

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

Todd Neale

April 10, 2023

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

Todd Neale

March 22, 2023

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

Todd Neale

September 21, 2021

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News ESC 2012

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

August 27, 2012

News Daily News

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

March 22, 2012

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

Advertisement

Lower Risk of Mortality for Shock Patients Transferred to Expert Centers

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Debating the Role of T-TEER in the Sickest Patients

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

ESC Congress 2011: Drugs, Devices Work Together

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content